Neurology Central

Antiplatelet therapies for secondary stroke prevention: an update on clinical and cost–effectiveness


Stroke exacts a huge toll physically, mentally and economically. Antiplatelet therapy is the cornerstone of secondary stroke prevention, and proven drugs available to successfully realize this therapeutic strategy for the long term include aspirin, dipyridamole plus aspirin and clopidogrel. However, government agencies, corporations, health plans and patients desire more information about the clinical- and cost–effectiveness of these established therapies in real-world settings.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.